6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
A clinical deep-dive into the Vyvanse (lisdexamfetamine) and alcohol interaction, covering pharmacodynamics, cardiovascular risks, impaired judgment, FDA label guidance, and practical harm-reduction strategies.
A deep dive into the Vyvanse caffeine interaction profile, covering cardiovascular risks, sleep disruption, anxiety amplification, and practical dosing guidance backed by primary literature.
A clinical review of the Vyvanse (lisdexamfetamine) and cannabis interaction profile, covering pharmacodynamics, cardiovascular risks, psychiatric effects, and practical guidance for patients and clinicians.
A complete clinical guide to the interaction between Vyvanse (lisdexamfetamine) and iodinated or gadolinium contrast agents used in CT, MRI, and angiography. Covers cardiovascular risk, timing protocols, and safety recommendations.
A detailed clinical review of how lisdexamfetamine (Vyvanse) interacts with nicotine and tobacco products, including shared cardiovascular risks, CNS effects, appetite suppression overlap, and evidence-based safety guidance.
A comprehensive clinical guide to Vyvanse (lisdexamfetamine) and vaccine interactions, covering immune response data, timing recommendations, alcohol, and drug-drug interactions.